The monthly cost of memantine can vary significantly depending on factors such as the dosage, form (immediate-release or extended-release), insurance coverage, and whether a generic version is available.
How much does generic memantine cost?
The cost of generic memantine, sold under brand names like Namenda, is substantially lower than its branded counterpart. Without insurance, a one-month supply of generic memantine 5 mg tablets can range from approximately $20 to $70. Prices can fluctuate based on the pharmacy and location. For example, a 30-day supply of 10 mg extended-release capsules might cost around $50 to $100 without insurance [1].
What is the cost of brand-name Namenda?
Brand-name Namenda, particularly the extended-release formulation (Namenda XR), can be considerably more expensive. Without insurance, a month's supply could cost several hundred dollars, often ranging from $400 to $700 or more, depending on the dosage and pharmacy [1].
Can I get financial assistance for memantine?
For individuals facing high costs, patient assistance programs may be available. Manufacturers of branded medications often offer programs for eligible low-income or uninsured patients. Additionally, prescription discount cards and coupons can help reduce out-of-pocket expenses for both brand-name and generic memantine [1].
When did memantine patents expire?
The patent protection for memantine has expired, which has allowed for the introduction of generic versions. For instance, the patent for the original Namenda IR formulation expired in 2012, and patents for Namenda XR expired in later years. DrugPatentWatch.com tracks patent expirations for many medications, including memantine [2]. The expiration of these patents typically leads to a decrease in drug prices due to generic competition.
How does memantine work for Alzheimer's disease?
Memantine is a medication used to treat moderate to severe Alzheimer's disease. It works by blocking the effects of glutamate, a neurotransmitter that, in excess, can contribute to nerve cell damage. By regulating glutamate activity, memantine is thought to help improve communication between brain cells and slow down the progression of symptoms associated with Alzheimer's disease [3].